Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are currently used to treat patients with diabetes. Previous studies have demonstrated that treatment with SGLT-2 inhibitors is accompanied by altered metabolic phenotypes. However, it has not been investigated whether the hypothalamic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ho Gyun, Jung, Il Hyeon, Park, Byong Seo, Yang, Hye Rim, Kim, Kwang Kon, Tu, Thai Hien, Yeh, Jung-Yong, Lee, Sewon, Yang, Sunggu, Lee, Byung Ju, Kim, Jae Geun, Nam-Goong, Il Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695712/
https://www.ncbi.nlm.nih.gov/pubmed/37915185
http://dx.doi.org/10.4093/dmj.2022.0261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695712/
https://www.ncbi.nlm.nih.gov/pubmed/37915185
http://dx.doi.org/10.4093/dmj.2022.0261

Ejemplares similares